• Issue

    Liver International: Volume 36, Issue 12

    1719-1878
    December 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information

  • Pages: 1719-1721
  • First Published: 19 November 2016

Review

Free Access

Gamma-glutamyltransferase—friend or foe within?

Setor K. Kunutsor, 
  • Pages: 1723-1734
  • First Published: 11 August 2016

Debates in Hepatology

Hereditary haemorrhagic telangiectasia: to transplant or not to transplant – is there a right time for liver transplantation?

Yannick D. Muller,  Roland Oppliger,  Romain Breguet,  Philippe Meyer,  Laura Rubbia-Brandt,  Pierre-Auguste Petignat,  Thomas Harr,  Eric Dayer,  Jörg D. Seebach, 
  • Pages: 1735-1740
  • First Published: 19 November 2016

Hereditary hemorrhagic telangiectasia: to transplant or not to transplant? – The PRO view

Sophie Dupuis-Girod,  Elisabetta Buscarini, 
  • Pages: 1741-1744
  • First Published: 19 November 2016

Hereditary haemorrhagic telangiectasia: to transplant or not to transplant? – The CON view

Carlo Sabbà, 
  • Pages: 1745-1747
  • First Published: 19 November 2016

Editorials

Free Access

Prognostic biomarkers and surrogate end points in PSC

Mette Vesterhus,  Espen Melum, 
  • Pages: 1748-1751
  • First Published: 19 November 2016

See Article on Page 1867

Free Access

Management of hepatitis B-related cirrhosis in the era of effective antiviral therapy

Vincent W. S. Wong, 
  • Pages: 1752-1754
  • First Published: 19 November 2016

See Article on Page 1755

Viral Hepatitis

Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung-Hung Su,  Tsung-Hui Hu,  Chi-Yi Chen,  Yi-Hsiang Huang,  Wan-Long Chuang,  Chun-Che Lin,  Chia-Chi Wang,  Wei-Wen Su,  Ming-Yao Chen,  Cheng-Yuan Peng,  Rong-Nan Chien,  Yi-Wen Huang,  Horng-Yuan Wang,  Chih-Lin Lin,  Sheng-Shun Yang,  Tsung-Ming Chen,  Lein-Ray Mo,  Shih-Jer Hsu,  Kuo-Chih Tseng,  Tsai-Yuan Hsieh,  Fat-Moon Suk,  Chi-Tan Hu,  Ming-Jong Bair,  Cheng-Chao Liang,  Yung-Chao Lei,  Tai-Chung Tseng,  Chi-Ling Chen,  Jia-Horng Kao, on behalf of the C-TEAM study group and the Taiwan Liver Diseases Consortium , 
  • Pages: 1755-1764
  • First Published: 16 September 2016

See Editorial on Page 1752

Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model

Salvatore Petta,  Vito Di Marco,  Savino Bruno,  Marco Enea,  Vincenza Calvaruso,  Vincenzo Boccaccio,  Sonia Rossi,  Antonio Craxì,  Calogero Cammà, 
  • Pages: 1765-1773
  • First Published: 10 May 2016

Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection

David A. Sheridan,  Behzad Hajarizadeh,  Fiona I. Fenwick,  Gail V. Matthews,  Tanya Applegate,  Mark Douglas,  Dermot Neely,  Bev Askew,  Gregory J. Dore,  Andrew R. Lloyd,  Jacob George,  Margaret F. Bassendine,  Jason Grebely, 
  • Pages: 1774-1782
  • First Published: 25 May 2016

Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial

Eric G. Meissner,  Mary McLaughlin,  Lindsay Matthews,  Ahmed M. Gharib,  Bradford J. Wood,  Elliot Levy,  Ralph Sinkus,  Kimmo Virtaneva,  Dan Sturdevant,  Craig Martens,  Stephen F. Porcella,  Zachary D. Goodman,  Bittoo Kanwar,  Robert P. Myers,  Mani Subramanian,  Colleen Hadigan,  Henry Masur,  David E. Kleiner,  Theo Heller,  Shyam Kottilil,  Joseph A. Kovacs,  Caryn G. Morse, 
  • Pages: 1783-1792
  • First Published: 27 May 2016

Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Jing-Houng Wang,  Yi-Hao Yen,  Chih-Chien Yao,  Chao-Hung Hung,  Chien-Hung Chen,  Tsung-Hui Hu,  Chuan-Mo Lee,  Sheng-Nan Lu, 
  • Pages: 1793-1799
  • First Published: 02 June 2016

Liver failure, Cirrhosis and their Complications

Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis

Xiaoming Wu,  Zhipeng Yao,  Lu Zhao,  Yan Zhang,  Muhua Cao,  Tao Li,  Wenbo Ding,  Yan Liu,  Ruijuan Deng,  Zengxiang Dong,  He Chen,  Valerie A. Novakovic,  Yayan Bi,  Junjie Kou,  Ye Tian,  Jin Zhou,  Jialan Shi, 
  • Pages: 1800-1810
  • First Published: 20 May 2016

Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis

Oriol Juanola,  Isabel Gómez-Hurtado,  Pedro Zapater,  Alba Moratalla,  Esther Caparrós,  Paula Piñero,  José M. González-Navajas,  Paula Giménez,  José Such,  Rubén Francés, 
  • Pages: 1811-1820
  • First Published: 23 May 2016

Cancer

A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma

Julien Edeline,  Jean-Frédéric Blanc,  Philip Johnson,  Boris Campillo-Gimenez,  Paul Ross,  Yuk Ting Ma,  Judy King,  Richard A. Hubner,  Kate Sumpter,  Suzanne Darby,  Jeff Evans,  Chinenye Iwuji,  Daniel Swinson,  Peter Collins,  Kinnari Patel,  Iqtedar Muazzam,  Daniel H. Palmer,  Tim Meyer, 
  • Pages: 1821-1828
  • First Published: 23 May 2016

The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people

Marc Connelly,  Michael G. Bruce,  Lisa Bulkow,  Mary Snowball,  Brian J. McMahon, 
  • Pages: 1829-1835
  • First Published: 25 May 2016

BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin

Yi-Hu Zheng,  Wei-Jian Hu,  Bi-Cheng Chen,  Tan-Hooi-Min Grahn,  Yan-Rong Zhao,  Hai-Li Bao,  Ye-Fan Zhu,  Qi-Yu Zhang, 
  • Pages: 1836-1847
  • First Published: 01 June 2016

Fatty Liver and Metabolic Liver Disease

ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity

Dries Bauters,  Pieter Spincemaille,  Lotte Geys,  David Cassiman,  Pieter Vermeersch,  Pierre Bedossa,  Ilse Scroyen,  Henri R. Lijnen, 
  • Pages: 1848-1859
  • First Published: 02 June 2016

The clinical value of controlled attenuation parameter for the noninvasive assessment of liver steatosis

Giovanna Ferraioli,  Carmine Tinelli,  Annalisa De Silvestri,  Raffaella Lissandrin,  Elisabetta Above,  Carolina Dellafiore,  Gianluigi Poma,  Marta Di Gregorio,  Laura Maiocchi,  Renato Maserati,  Carlo Filice, 
  • Pages: 1860-1866
  • First Published: 21 July 2016

Autoimmune and Cholestatic Liver Disease

Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value

Elisabeth M. G. de Vries,  Junfeng Wang,  Mariska M. G. Leeflang,  Kirsten Boonstra,  Rinse K. Weersma,  Ulrich H. Beuers,  Ronald B. Geskus,  Cyriel Y. Ponsioen, 
  • Pages: 1867-1875
  • First Published: 04 March 2016

See Editorial on Page 1748

Letters to the Editor

HCC classification and HCC scoring system: a win-win combination for prognosis and treatment recommendations

Xavier Adhoute,  Guillaume Penaranda,  Jean-Luc Raoul,  Marc Bourlière, 
  • Pages: 1876-1877
  • First Published: 09 April 2016

Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels

Alessandro Cucchetti,  Rita Golfieri,  Franco Trevisani,  on the behalf of the Italian Liver Cancer (ITA.LI.CA) Group , 
  • Page: 1877
  • First Published: 12 July 2016

Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels

Yunfei Yuan,  Wei He,  Binkui Li, 
  • Page: 1878
  • First Published: 19 November 2016